Social Media Ideas for Biocon Limited

Pharma Stock Jumps After Securing ₹515 Cr Contracts from Malaysia’s Ministry of Health

Synopsis: Biocon strengthened its Malaysia presence after partner Duopharma secured insulin contracts worth over ₹514 crore, supporting affordable diabetes treatment and expanding...

Biocon slips despite BBL turning wholly-owned subsidiary

On Monday, Biocon completed the acquisition of 1,15,36,956 equity shares of Biocon Biologics from 127 selling shareholders, making BBL a wholly-owned subsidiary with effect from th...

Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake sale

Biocon shares experienced a significant jump of over 6% on Tuesday. Viatris-owned Mylan intends to sell a substantial stake, exiting the Indian drugmaker. This stake sale represent...

Biocon founder Kiran Mazumdar-Shaw says India needs patient capital for Biotech

Biocon founder says India has the talent and scientific capability to build global biotech champions, but lacks the funding ecosystem needed to scale them

Ipca inks licensing agreement with Bhami Research for biologics delivery platform access

Licencing agreement grants Ipca access to Bhami Research’s proprietary high-concentration subcutaneous biologics delivery platform for the development and commercialisation of mult...

Kiran Mazumdar-Shaw founded Immuneel Therapeutics raises Rs 100 Cr in Series B Funding

Immuneel Therapeutics will utilise the funding round for multiple initiatives that include expanding manufacturing capacity, R&D and international expansion.

MSCI Review On August 12: Laurus Labs, Biocon Emerge As Strongest Candidates

Among the likely beneficiaries, Laurus Labs and Biocon have been assigned a high probability of moving from the MSCI India Small Cap Index to the MSCI India Standard Index.

'GLP-1 alters...': Kiran Mazumdar-Shaw sounds caution as Nithin Kamath flags weak drug demand

Kamath believes affordability is no longer the biggest obstacle. According to him, convincing people to remain on a weekly injection indefinitely is proving to be a much harder pro...

Sun Pharma to acquire Innovcare Lifesciences in ₹271 crore deal

Why Is Concord Biotech Stock Up by 8% Today?

Synopsis: Concord Biotech Ltd shares jumped 8% after USFDA approval for its ANDA of Mycophenolate Mofetil oral suspension (200 mg/mL). The drug is an immunosuppressant for transpla...

Beigene

Beigene Anonymous (not verified) Mon, 05/25/2026 - 11:38 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...

Shantha Biologics to provide cartridge fill-finish services for Novo Nordisk

IPCA Labs, Biocon, Laurus Labs, Gland Pharma, Aurobindo, Sun Pharma shares hit 52-week highs; what's next?

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, JB Chemicals & Pharmaceuticals Ltd, Manki...

Novo Nordisk India rolls-out once-weekly basal insulin Awiqli

The product will be imported from Denmark and is priced at ₹2611 for a 1 ml pen (700 insulin units)

Sanstar Limited Announces Strategic Partnership with Ingredion Incorporated Through Preferential Issue and Joint Venture

Multibagger Ashish Kacholia Stock in Which DIIs Nearly Tripled Their Stake to Keep on Your Radar

Synopsis: Institutional investors nearly tripled their stake in a Himachal Pradesh-based oncology pharma company in a single quarter, even as the stock rallied sharply – a vote of...

Dr Reddy’s launches Bosutinib tablets in US market

The company has collaborated with MSN Laboratories on the product

InduPro Licenses Lonza’s Linker Payload Technologies and Bioconjugation Platforms

Lonza and InduPro signed the licensing agreement to develop differentiated therapeutic approaches designed to address complex diseases such as cancer, where precision targeting and...

India's biotech push reaches an inflection point, but funding remains the missing piece

Historically, Indian pharmaceutical companies have focused on generics and services businesses, which carry lower risk and shorter development

India’s lifesciences sector sees momentum build in innovation: BCG -HealthKois report

Private equity and venture capital investment in pharma rose 2.1x in five years to $ 731 million for the year ended March 2026, and biotech startups grew from roughly 1,500 to 2,40...

<![CDATA[Eli Lilly and Abbisko Announce Drug Development Collaboration]]>

Merck launches GCC in Bengaluru

Merck’s Bengaluru GCC to bring together approximately 3,300 professionals

Lilly launches cancer therapy Tanstrive for patients with advanced or metastatic solid tumors with a RET gene alteration

Twice a day oral drug is priced at ₹2.15 lakh for two weeks treatment

5 Indian CDMO Stocks Benefiting from the Global Pharma Outsourcing Boom

Synopsis: Global pharmaceutical companies are rapidly diversifying their manufacturing supply chains as geopolitical tensions, regulatory changes and the proposed U.S. BIOSECURE Ac...